Addex Therapeutics Ltd. — Form D
Addex Therapeutics Ltd. of GENEVA, V8, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-13. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-13
- Form: D
- Accession: 0001231919-23-000017
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.7M
- Amount sold: $3.7M
- Investors: 1
- Date of first sale: 2023-04-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-478677
Issuer
- Name: Addex Therapeutics Ltd.
- CIK: 0001574232
- Entity type: Corporation
- Jurisdiction: SWITZERLAND
- Address: CHEMIN DES MINES 9, GENEVA, V8, CH-1202
- Phone: 01141228841555
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Timothy Dyer | Director | Geneva, V8 |
| Raymond Hill | Director | New York, NY |
| Vincent Lawton | Director | Geneva, V8 |
| Isaac Manke | Director | New York, NY |
| ROGER MILLS | Director | CHARLOTTE, NC |
| Jake Nunn | Director | Menlo Park, CA |
| Timothy Dyer | Executive Officer | Geneva, V8 |
| Mikhail Kalinichev | Executive Officer | Geneva, V8 |
| Robert Lutjens | Executive Officer | Geneva, V8 |
| ROGER MILLS | Executive Officer | CHARLOTTE, NC |
| Jean-Philippe Rocher | Executive Officer | Geneva, V8 |
Other filings by this issuer (2)
More